Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You might be able to get the $99 per month from Blink which is what they charge me with no coverage.
Have you tried Blink RX, they charge me $99 for 30 days. Since I switched to Aetna in January I will be back to $9 for 90.
Sorry, the full name of the plan is Aetna open access basic….. no deductible.
Federal employees who lost Vascepa coverage under BCBS can switch now to Aetna basic and get Vascepa as the preferred brand. I am saying goodbye to BCBS but will file my complaints with OPM and the Maryland AG for forcing patients to take a drug that is not approved for Cardiovascular risk reduction.
Capt, do you happen to have handy the links to the Vascepa and generic labels? If not no worries I will look for them. I only have the V hard copy.
Rosemount, a suggestion if they try to swap your script and it’s a tactic I plan to use. I have one more appeal at BCBS and if they say no to V but yes to the generic then I plan to file an AG complaint. The issue I believe the state AG can address is the one of fraud. A pharmacy or insurance company cannot tell you they will only cover or fill the drug that is not FDA approved for your condition. Only your doctor can prescribe off label and if your doctor writes v then someone is committing fraud. In addition, if you call the pharmacy and find V is cheaper it furthers the fraud argument.
I suggest everyone do this and it only takes on state AG to take up the issue to cause all insurance companies to pause this practice.
Can’t we just sue on the basis of the label? If it’s not approved for the condition the generic should not be authorized? Moreover, the brand in two places I checked is cheaper leading me to believe there is some sort of discounting back to the insurance company. I wonder if there is a racketeering angle.
Sign me up for the class action…. I am impacted as well.
I think consumers need to punch these companies in the mouth. I can certainly understand covering generics when the labels are equal. But when the generic is not approved for the condition it’s fraud in my opinion. Insurance companies are committing consumer fraud and the AG incentive is nice big fines.
I will and really hope they approve it because it’s such a chore filing these things.
Capt, I am going through my last appeal with FEP BC/BS and taking the stance that the generic is not approved for my condition. What took so long is waiting for my Doctor to say to them V is for CVD risk reduction. I had a tough time convincing him the labels are different and the issue of possible oxidation with the generic. If they deny my appeal I told BCBS and my doctor I will file a state AG complaint of fraud on the basis the insurance is or practicing medicine through drug coverage. They can’t tell me they will only cover the drug not approved for my condition. I swear I believe we have a class action case.
If you scroll to the next drug Keytruda got the same treatment. Looks like all the EU players are looking to save some short term money and pay down the road for the MI or stroke. Inflation from the Ukraine war and our lack of oil output to meet demand is driving global inflation. Everyone is cutting back.
Did they ever provide an update on the once a day formula as a way to recapture the US? I would like to take a few less pills a day.
Can’t understand why it takes so long to deal with these cases. Just a big waste of taxpayer money.
Whatever happened to the infringement appeal against Hikma?
I am having the same fight and you need to have your doctor state your script is for cardiovascular risk reduction, reduce it indication. The generic is not approved. I have already told Fep BCBS I am filing a fraud complaint with my state AG. I just need to make sure my doctor sends them a clear message it’s for reduce it indication. We need to start filling fraud complaints on the insurance companies. They can’t tell you to take a drug that is not approved for your condition. I think these companies are getting rebates from these pharmacy management companies.
And hopefully an uptrend in sales and earnings.
This is usually a volatile period for the market and thanks to Bidenomics everything gets crushed.
In my opinion, this is nothing more than penny shorts trying to make a fast buck on fund quarter/ year end close. They are hedging we will see funds unload shares next week and they can continue real quick. The down volume has been low the whole past few weeks. I am mad at myself for buying a little more at $1.05 and will look to by more on 27 th. In my opinion, they will try to drop it as low as possible on that day and then cover. If funds don’t unload the shorts are screwed.
I don’t expect any positive news from Amarin until the start of October. Denner knows quarter- year -end close is a waste of good press.
Another MO conspiracy moron who distorts the reduce it results and then tries to compare it to results from DHA/EPA mix. I think he needs a lesson from the captain.
It’s possible it’s a timed hit piece for the Penny playing shorts or someone trying to accumulate. Funny how we are down hard and close a penny down from the prior day.
With almost a dollar a share in cash, no debt and revenues about to rise the current price is absurd and only reflects the uncertainty of the current management strategy.
FWIW, we should have known Italy would pass at this time. They are almost as broke as Greece, hit hardest by COVID and dealing with an immigration crisis.
Not sure why chat lists the trial as complete, the clinical site still has September 2023 as the end date.
https://classic.clinicaltrials.gov/ct2/show/NCT02719327
I think the real hold up in the sale is the anti trust suit. Once that is over you will see some M& A rumors. With Amarin’s recent legal losses I am sure it is buyer beware until it’s resolved.
Last time I checked generic prices were $20 more than Vascepa and I was quoted $230 for 30 days of the generic and $210 for V. I guess it’s these owned pharmacy middlemen men using kickbacks to insurance providers as the only explanation why GV is on a better tier.
A comedian, have you listened to his podcasts lately? Not to mention, he has a 40 million audience.
Somehow we need to get Doctor Bhatt on Joe Rogan to talk about CVD.
Is there a way you can send it to Denner? Maybe he can find some lawyers that can actually win.
Thanks for posting and it sounds like he would be a big fan of the combo pill.
Don’t overlook RFK jr with Biden hiding from debates. Name recognition and some of his messaging might appeal to the moderates and normal Dems. I wish Vegas had betting on this.
In my opinion, splitting Amarin rights up amongst 3 big pharmas might yield the biggest return. Sell Europe to one pharma, north and South America to another and the ROW to another. They get V, the rights to once a day and the combo. Amarin splits the inventory with the new owners and remaining cash goes to shareholders.
So far I am losing, I need my doctor to call them to discuss what else they need. He only practices once per week, the other 4 days he is a chief medical officer at the FDA. Hoping BCBS pisses him off and the FDA can do something.
Lots of suggestions and I do agree that to proceed with a lawsuit we need to test all of them from sealed containers and different batches,
I am not the legal expert and just wondering if testing one opened bottle is enough to file a valid complaint with the FDA and enough to solicit GV patients for a class action suit.
At this point I think it is on Amarin shareholders once again to point out potential Fraud. I really hate management.
Duke, do you still have your bottle of GV?
I can email a few labs on prices.
Thanks Capt for the link.
Duke, can you post the FDA testing requirements? I would think we can find a lab and set up a go fund me to have it done. If it comes back as junk you should have a conversation with Marjac.
How do these vultures make any money when they totally screwed demand. They will all be fighting over weekly 100k. The real losers aside from us shareholders are all those people suffering from CVD that will never know they have a great option with V. That Nevada ruling will result in the premature deaths of tens of thousands.
Not at all and that is my point….. no news does not mean bad news.
I think as the largest or one of the largest they can’t really comment without running afoul of either insider trading rules or something else that could impact the price of the stock one way or another. Just look at all the shareholder suits against Musk for opening his mouth. I would not take silence as a negative.
It would be great if we could get a picture of PWO leaving Amarin carrying his box.
And Fire KM and claw back the grants!
Hoping Denner fires KM now and takes over the title of Chairman.
Can you use the savings coupon under the plan?
It’s time we kick these people in the teeth. FEP Blue increases the co pay for your primary care doctor by 50% and premiums by %15% but drops coverage for a drug that will reduce their overall costs of CVD care. What makes this even dumber is that GV is a higher retail price at my pharmacy.